Events

« All Events

DCAT Week 2026

March 23 - March 26

Join us at Omni Berkshire Place Hotel, New York City, NY

March 23 – 26, 2026

If you are attending DCAT Week in New York this March, we would love to connect with you!

Avid Bioservices brings decades of experience in biologics development and manufacturing, supporting innovators from early-stage development through commercial production. Whether you’re scaling up a complex biologic of redefining your process, our team is ready to explore how our tailored CDMO solutions can support your goals.

 

 

Why Meet with Avid Bioservices?

• 30+ years of biologics development experience
• Flexible CDMO services from clinical to commercial production
• Unparalleled quality and operational excellence
• Best-in-class U.S.-based facilities
• We approach every customer and molecule with personalized care
• Onshoring with a U.S.-based CDMO reduces supply chain risks and helps navigate global tariffs

 

Meet Our Experts

Our team will be onsite to discuss:

• Process development and scale-up for biologics
• Upstream and downstream optimization strategies
• Analytical characterization and QC for complex biologics
• CGMP manufacturing for clinical and commercial supply
• How onshoring can enhance supply chain resilience and reduce geopolitical risk

 

Add to calendar

• Google Calendar
• iCalendar
• Outlook 365
• Outlook Live

Details

Start:

March 23

End:

March 26

Event Category:

Conference

Venue

Omni Berkshire Place

New York, NY United States

Related Events

• 

  BPI West 2026

  March 9 - March 11

News

• Avid Bioservices Appoints Rich McAvoy as Chief Business Officer

  January 15, 2026

  Seasoned business and finance leader brings growth mindset to support Avid’s next phase expansion and client execution   TUSTIN, Calif. — [January 15, 2026] — Avid Bioservices, a leading contract development […]

  Read more

• Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer

  October 7, 2025

  The newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth.    TUSTIN, Calif., November 10, 2025 – Avid […]

  Read more

• Avid Bioservices Welcomes Kenneth Bilenberg as New CEO

  September 15, 2025

  Tustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]

  Read more

• CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production

  August 5, 2025

  SOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]

  Read more

• GHO & Ampersand Complete Acquisition of Avid Bioservices

  February 5, 2025

  Download PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]

  Read more

• Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger

  February 5, 2025

  Download PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]

  Read more

< View Older News